SUBSCRIBE NOW

SIGHT

Be informed. Be challenged. Be inspired.

Don’t expect first COVID-19 vaccinations until early 2021 – WHO’s Ryan

Geneva/Zurich, Switzerland
Reuters

Researchers are making “good progress” in developing vaccines against COVID-19, with a handful in late-stage trials, but their first use cannot be expected until early 2021, a World Health Organization expert said on Wednesday.

WHO is working to ensure fair vaccine distribution, but in the meantime it is key to suppress the virus’s spread, said Mike Ryan, head of WHO’s emergencies programme, as daily new cases around the globe are at near-record levels. 

WHO Mike Ryan May 2019

Mike Ryan, executive director of the World Health Organisation attends a news conference on the Ebola outbreak in the Democratic Republic of Congo at the United Nations in Geneva, Switzerland, on 3rd May, 2019. PICTURE: Reuters/Denis Balibouse/File photo.

“We’re making good progress,” Ryan said, noting that several vaccines were now in phase three trials and none had failed, so far, in terms of safety or ability to generate an immune response.

“Realistically it is going to be the first part of next year before we start seeing people getting vaccinated,” he told a public event on social media.

WHO was working to expand access to potential vaccines and to help scale-up production capacity, Ryan said. 

“And we need to be fair about this, because this is a global good. Vaccines for this pandemic are not for the wealthy, they are not for the poor, they are for everybody,” he said.

The US Government will pay $US1.95 billion to buy 100 million doses of a COVID-19 vaccine being developed by Pfizer Inc and German biotech BioNTech if it proves safe and effective, the companies said. 

Ryan also cautioned schools to be careful about re-opening until community transmission of COVID-19 is under control. Debate in the United States over restarting education has intensified, even as the pandemic flares up in dozens of states. 

“We have to do everything possible to bring our children back to school, and the most effective thing we can do is to stop the disease in our community,” he said. “Because if you control the disease in the community, you can open the schools.”

 

Donate



sight plus logo

Sight+ is a new benefits program we’ve launched to reward people who have supported us with annual donations of $26 or more. To find out more about Sight+ and how you can support the work of Sight, head to our Sight+ page.

Musings

TAKE PART IN THE SIGHT READER SURVEY!

We’re interested to find out more about you, our readers, as we improve and expand our coverage and so we’re asking all of our readers to take this survey (it’ll only take a couple of minutes).

To take part in the survey, simply follow this link…

Leave a Reply

Your email address will not be published. Required fields are marked *

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.